Vitamins in dialysis: who, when and how much?

References

• Pecoits-Filho R, Lindholm B, Stenvinkel P. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome – the heart of the matter. Nephrol Dial Transplant. 2002;17(Suppl. 11):28–31
   PubMed Web of Science ®Google Scholar
• Rock CL, Jahnke MG, Gorenflo DW, Swartz RD, Messana JM. Racial group differences in plasma concentrations of antioxidant vitamins and carotenoids in hemodialysis patients. Am J Clin Nutr. 1997;65(3):844–850
   PubMed Web of Science ®Google Scholar
• Holden RM, Ki V, Ross Morton A, Clase C. Fat-soluble vitamins in advanced CKD/ESKD: a review. In: Seminars in Dialysis. 3rd ed., Vol. 25 (May–June) 2012;334–343
   Google Scholar
• Kalantar-Zadeh K, Kopple JD. Trace elements and vitamins in maintenance dialysis patients. Adv Ren Replace Ther. 2003;10(3):170–182
   PubMedGoogle Scholar
• Fissell RB, Bragg-Gresham JL, Gillespie BW, et al. International variation in vitamin prescription and association with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004;44(2):293–299
   PubMedGoogle Scholar
• Domröse U, Heinz J, Westphal S, Luley C, Neumann KH, Dierkes J. Vitamins are associated with survival in patients with end-stage renal disease: a 4-year prospective study. Clin Nephrol. 2007;67(4):221–229
   PubMedGoogle Scholar
• Coombes JS, Fassett RG. Antioxidant therapy in hemodialysis patients: a systematic review. Kidney Int. 2012;81(3):233–246
   PubMed Web of Science ®Google Scholar
• Chazot C, Kopple JD. Vitamin metabolism and requirements in renal disease and renal failure. In: Kopple JD, Massry SG, eds. Nutritional Management of Renal Disease. 2nd ed., Philadelphia, USA: Lipincott Williams and Wilkins; 2004:315–356
   Google Scholar
• Pelton R, LaValle JB, Hawkins E, Krinsky DL, eds. Drug-Induced Nutrient Depletion Handbook. Hudson, OH: Lexi-Comp; 1999:258
   Google Scholar
• Fouque M, Vennegoor P, Ter Wee, et al. EBPG Guideline on Nutrition. Nephrol Dial Transplant. 2007;22(Suppl. 2):ii45–ii87
   PubMedGoogle Scholar
• Heinz J, Domröse U, Westphal S, Luley C, Neumann KH, Dierkes J. Washout of water-soluble vitamins and of homocysteine during hemodialysis: effect of high-flux and low-flux dialyser membranes. Nephrology (Carlton). 2008;13(5):384–389
   PubMedGoogle Scholar
• Boeschoten EW, Schrijver J, Krediet RT, Schreurs WH, Arisz L. Deficiencies of vitamins in CAPD patients: the effect of supplementation. Nephrol Dial Transplant. 1988;3(2):187–193
   PubMedGoogle Scholar
• Descombes E, Hanck AB, Fellay G. Water soluble vitamins in chronic hemodialysis patients and need for supplementation. Kidney Int. 1993;43(6):1319–1328
   PubMed Web of Science ®Google Scholar
• Hung SC, Hung SH, Tarng DC, Yang WC, Chen TW, Huang TP. Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 2001;38(5):941–947
   PubMed Web of Science ®Google Scholar
• Ueda K, Takada D, Mii A, et al. Severe thiamine deficiency resulted in Wernicke's encephalopathy in a chronic dialysis patient. Clin Exp Nephrol. 2006;10(4):290–293
   PubMedGoogle Scholar
• Nascimento MM, Suliman ME, Murayama Y, et al. Effect of high-dose thiamine and pyridoxine on advanced glycation end products and other oxidative stress markers in hemodialysis patients: a randomized placebo-controlled study. J Ren Nutr. 2006;16(2):119–124
   PubMedGoogle Scholar
• Frank T, Bitsch R, Maiwald J, Stein G. High thiamine diphosphate concentrations in erythrocytes can be achieved in dialysis patients by oral administration of benfontiamine. Eur J Clin Pharmacol. 2000;56(3):251–257
   PubMedGoogle Scholar
• Descombes E, Boulat O, Perriard F, Fellay G. Water-soluble vitamin levels in patients undergoing high-flux hemodialysis and receiving long-term oral postdialysis vitamin supplementation. Artif Organs. 2000;24(10):773–778
   PubMed Web of Science ®Google Scholar
• Skoupy S, Födinger M, Veitl M, et al. Riboflavin is a determinant of total homocysteine plasma concentrations in end-stage renal disease patients. J Am Soc Nephrol. 2002;13(5):1331–1337
   PubMedGoogle Scholar
• Cooke HM. Lovastatin- and niacin-induced rhabdomyolysis. Hosp Pharm. 1994;29:33–34
   Google Scholar
• Berns JS. Niacin and Related Compounds for Treating Hyperphosphatemia in Dialysis Patients Seminars in Dialysis. 3rd ed., Vol. 21 (May–June) 2008:203–205
   Google Scholar
• Cheng SC, Young DO, Huang Y, Delmez JA, Coyne DW. A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients. Clin J Am Soc Nephrol. 2008;3(4):1131–1138
   PubMed Web of Science ®Google Scholar
• Toriyama T, Matsuo S, Fukatsu A, et al. Effects of high-dose vitamin B6 therapy on microcytic and hypochromic anemia in hemodialysis patients. Nihon Jinzo Gakkai Shi. 1993;35(8):975–980
   PubMedGoogle Scholar
• Corken M, Porter J. Is vitamin B(6) deficiency an under-recognized risk in patients receiving hemodialysis? A systematic review: 2000–2010. Nephrology (Carlton). 2011;16(7):619–625
   PubMedGoogle Scholar
• Mydlík M, Derzsiová K, Svác J, Dlhopolcek P, Zemberová E. Peritoneal clearance and peritoneal transfer of oxalic acid, vitamin C, and vitamin B6 during continuous ambulatory peritoneal dialysis. Artif Organs. 1998;22(9):784–788
   PubMedGoogle Scholar
• Leblanc M, Pichette V, Geadah D, Ouimet D. Folic acid and pyridoxal-5'-phosphate losses during high-efficiency hemodialysis in patients without hydrosoluble vitamin supplementation. J Ren Nutr. 2000;10(4):196–201
   PubMedGoogle Scholar
• Kasama R, Koch T, Canals-Navas C, Pitone JM. Vitamin B6 and hemodialysis: the impact of high-flux/high-efficiency dialysis and review of the literature. Am J Kidney Dis. 1996;27(5):680–686
   PubMedGoogle Scholar
• Bostom AG, Shemin D, Lapane KL, et al. High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients. Kidney Int. 1996;49(1):147–152
   PubMed Web of Science ®Google Scholar
• Friedman AN. Pharmacologic B-vitamin therapy for hyperhomocysteinemia in dialysis patients: has the time come? Nutr Clin Care. 2002;5(1):20–24
   PubMedGoogle Scholar
• Nakhoul F, Abassi Z, Plawner M, et al. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients. Isr Med Assoc J. 2004;6(4):213–217
   PubMedGoogle Scholar
• Righetti M, Tommasi A, Lagona C, La Rosa L, Uccellini M, Sessa A. Effective homocysteine-lowering vitamin B treatment in peritoneal dialysis patients. Perit Dial Int. 2004;24(4):373–377
   PubMedGoogle Scholar
• Moriwaki K, Kanno Y, Nakamoto H, Okada H, Suzuki H. Vitamin B6 deficiency in elderly patients on chronic peritoneal dialysis. Adv Perit Dial. 2000;16:308–312
   PubMedGoogle Scholar
• Okada H, Moriwaki K, Kanno Y, et al. Vitamin B6 supplementation can improve peripheral polyneuropathy in patients with chronic renal failure on high-flux hemodialysis and human recombinant erythropoietin. Nephrol Dial Transplant. 2000;15(9):1410–1413
   PubMed Web of Science ®Google Scholar
• Ross EA, Shah GM, Reynolds RD, Sabo A, Pichon M. Vitamin B6 requirements of patients on chronic peritoneal dialysis. Kidney Int. 1989;36(4):702–706
   PubMedGoogle Scholar
• Endresen GK, Husby G. Folate supplementation during methotrexate treatment of patients with rheumatoid arthritis. An update and proposals for guidelines. Scand J Rheumatol. 2001;30:129
   Google Scholar
• Lasseur C, Parrot F, Delmas Y, et al. Impact of high-flux/high-efficiency dialysis on folate and homocysteine metabolism. J Nephrol. 2001;14:32–35
   PubMedGoogle Scholar
• Fehrman-Ekholm I, Lotsander A, Logan K, Dunge D, Odar-Cederlöf I, Kallner A. Concentrations of vitamin C, vitamin B12 and folic acid in patients treated with hemodialysis and on-line hemodiafiltration or hemofiltration. Scand J Urol Nephrol. 2008;42(1):74–80
   PubMed Web of Science ®Google Scholar
• KDOQI. Clinical practice guidelines in cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;S3:16–153
   Google Scholar
• Koyama K, Usami T, Takeuchi O, Morozumi K, Kimura G. Efficacy of methylcobalamin on lowering total homocysteine plasma concentrations in hemodialysis patients receiving high-dose folic acid supplementation. Nephrol Dial Transplant. 2002;17(5):916–922
   PubMed Web of Science ®Google Scholar
• van Guldener C, Janssen MJ, Lambert J, et al. No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinanemia in hemodialysis patients. Nephrol Dial Transplant. 1998;13(1):106–112
   PubMedGoogle Scholar
• Sunder-Plassmann G, Fodinger M, Buchmayer H, et al. Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study. J Am Soc Nephrol. 2000;11:1106–1116
   PubMed Web of Science ®Google Scholar
• Ingrosso D, Cimmino A, Perna AF, et al. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinanemia in patients with uratemia. Lancet. 2003 17;361(9370):1693–1699
   PubMed Web of Science ®Google Scholar
• Nakamura H, Kumagai H, Itoh T. Randomized controlled trial of the effect of short-term coadministration of methylcobalamin and folate on serum ADMA concentration in patients receiving long-term hemodialysis. Am J Kidney Dis. 2010;55(6):1069–1078
   PubMedGoogle Scholar
• Wrone EM, Hornberger JM, Zehnder JL, McCann LM, Coplon NS, Fortmann SP. Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease. J Am Soc Nephrol. 2004;15(2):420–426
   PubMedGoogle Scholar
• Jamison RL, Hartigan P, Kaufman JS, et al. Veterans Affairs Site Investigators. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA. 2007;298(10):1163–1170
   PubMed Web of Science ®Google Scholar
• Leung J, Larive B, Dwyer J, et al. Folic acid supplementation and cardiac and stroke mortality among hemodialysis patients. J Ren Nutr. 2010;20(5):293–302
   PubMedGoogle Scholar
• Qin X, Huo Y, Langman CB, et al. Folic acid therapy and cardiovascular disease in ESRD or advanced chronic kidney disease: a meta-analysis. Clin J Am Soc Nephrol. 2011;6(3):482–488
   PubMed Web of Science ®Google Scholar
• Jardine MJ, Kang A, Zoungas S, et al. The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis. BMJ. 2012;344:e3533
   PubMed Web of Science ®Google Scholar
• de Koning L, Hu FB. Homocysteine lowering in end-stage renal disease is there any cardiovascular benefit? Circulation. 2010;121:1379–1381
   PubMedGoogle Scholar
• Righetti M. Protective effect of vitamin B therapy on bone and cardiovascular disease. Recent Pat Cardiovasc Drug Discov. 2009;4:37–44
   PubMedGoogle Scholar
• Obeid R, Kuhlmann MK, Köhler H, Herrmann W. Response of homocysteine, cystathionine, and methylmalonic acid to vitamin treatment in dialysis patients. Clin Chem. 2005;51(1):196–201
   PubMedGoogle Scholar
• Hoffer LJ, Elian KM. Parenteral vitamin B12 therapy of hyperhomocysteinemia in end-stage renal disease. Clin Invest Med. 2004;27(1):10–13
   PubMedGoogle Scholar
• Heinz J, Kropf S, Domrose U, et al. B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease. Results of a randomized controlled trial. Circulation. 2010;121:1432–1438
   PubMed Web of Science ®Google Scholar
• Su VC, Shalansky K, Jastrzebski J, et al. Parenteral vitamin B12 in macrocytic hemodialysis patients reduced MMA levels but did not change mean red cell volume or hemoglobin. Clin Nephrol. 2011;75(4):336–345
   PubMedGoogle Scholar
• Trimarchi H, Forrester M, Schropp J, Pereyra H, Freixas EA. Low initial vitamin B12 levels in Helicobacter pylori – positive patients on chronic hemodialysis. Nephron Clin Pract. 2004;96(1):c28–c32
   PubMedGoogle Scholar
• Rostand SG. Vitamin B12 levels and nerve conduction velocities in patients undergoing maintenance hemodialysis. Am J Clin Nutr. 1976;29(7):691–697
   PubMedGoogle Scholar
• Singer R, Rhodes HC, Chin G, Kulkarni H, Ferrari P. High prevalence of ascorbate deficiency in an Australian peritoneal dialysis population. Nephrology (Carlton). 2008;13(1):17–22
   PubMedGoogle Scholar
• Wang S, Eide TC, Sogn EM, Berg KJ, Sund RB. Plasma ascorbic acid in patients undergoing chronic hemodialysis. Eur J Clin Pharmacol. 1999;55(7):527–532
   PubMedGoogle Scholar
• Morena M, Cristol JP, Bosc JY, et al. Convective and diffusive losses of vitamin C during hemodiafiltration session: a contributive factor to oxidative stress in hemodialysis patients. Nephrol Dial Transplant. 2002;17(3):422–427
   PubMed Web of Science ®Google Scholar
• Khajehdehi P, Mojerlou M, Behzadi S, Rais-Jalali GA. A randomized, double-blind, placebo-controlled trial of supplementary vitamins E, C and their combination for treatment of hemodialysis cramps. Nephrol Dial Transplant. 2001;16(7):1448–1451
   PubMed Web of Science ®Google Scholar
• Cross JM, Donald AE, Nuttall SL, Deanfield JE, Woolfson RG, Macallister RJ. Vitamin C improves resistance but not conduit artery endothelial function in patients with chronic renal failure. Kidney Int. 2003;63(4):1433–1442
   PubMedGoogle Scholar
• Sato M, Matsumoto Y, Morita H, Takemura H, Shimoi K, Amano I. Effects of vitamin supplementation on microcirculatory disturbance in hemodialysis patients without peripheral arterial disease. Clin Nephrol. 2003;60(1):28–34
   PubMedGoogle Scholar
• Deicher R, Ziai F, Bieglmayer C, Schillinger M, Hörl WH. Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients. J Am Soc Nephrol. 2005;16(6):1811–1818
   PubMedGoogle Scholar
• Richter A, Kuhlmann MK, Seibert E, Kotanko P, Levin NW, Handelman GJ. Vitamin C deficiency and secondary hyperparathyroidism in chronic hemodialysis patients. Nephrol Dial Transplant. 2008;23(6):2058–2063
   PubMedGoogle Scholar
• Gholipour Baradari A, Emami Zeydi A, Espahbodi F, Aarabi M. The effect of intravenous vitamin C on the phosphorus level reduction in hemodialysis patients: a double blind randomized clinical trial. Med Glas (Zenica). 2012;9(1):37–41
   PubMedGoogle Scholar
• Khajehdehi P. Effect of vitamins on the lipid profile of patients on regular hemodialysis. Scand J Urol Nephrol. 2000;34(1):62–66
   PubMed Web of Science ®Google Scholar
• Gastaldello K, Vereerstraeten A, Nzame-Nze T, Vanherweghem JL, Tielemans C. Resistance to erythropoietin in iron-overloaded hemodialysis patients can be overcome by ascorbic acid administration. Nephrol Dial Transplant. 1995;10(Suppl. 6):44–47
   PubMedGoogle Scholar
• Tarng DC, Huang TP. A parallel, comparative study of intravenous iron versus intravenous ascorbic acid for erythropoietin-hyporesponsive anaemia in hemodialysis patients with iron overload. Nephrol Dial Transplant. 1998;13(11):2867–2872
   PubMed Web of Science ®Google Scholar
• Lin CL, Hsu PY, Yang HY, Huang CC. Low dose intravenous ascorbic acid for erythropoietin-hyporesponsive anemia in diabetic hemodialysis patients with iron overload. Ren Fail. 2003;25(3):445–453
   PubMed Web of Science ®Google Scholar
• Keven K, Kutlay S, Nergizoglu G, Ertürk S. Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients. Am J Kidney Dis. 2003;41(6):1233–1239
   PubMedGoogle Scholar
• Deicher R, Ziai F, Habicht A, Bieglmayer C, Schillinger M, Hörl WH. Vitamin C plasma level and response to erythropoietin in patients on maintenance hemodialysis. Nephrol Dial Transplant. 2004;19(9):2319–2324
   PubMedGoogle Scholar
• Attallah N, Osman-Malik Y, Frinak S, Besarab A. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia. Am J Kidney Dis. 2006;47(4):644–654
   PubMedGoogle Scholar
• Tarng DC, Hung SC, Huang TP. Effect of intravenous ascorbic acid medication on serum levels of soluble transferrin receptor in hemodialysis patients. J Am Soc Nephrol. 2004;15(9):2486–2493
   PubMedGoogle Scholar
• Deved V, Poyah P, James MT, et al. Alberta Kidney Disease Network. Ascorbic acid for anemia management in hemodialysis patients: a systematic review and meta-analysis. Am J Kidney Dis. 2009;54(6):1089–1097
   PubMed Web of Science ®Google Scholar
• De Vriese AS, Borrey D, Mahieu E, et al. Oral vitamin C administration increases lipid peroxidation in hemodialysis patients. Nephron Clin Pract. 2008;108(1):c28–c34
   PubMedGoogle Scholar
• Ferretti G, Bacchetti T, Masciangelo S, Pallotta G. Lipid peroxidation in hemodialysis patients: effect of vitamin C supplementation. Clin Biochem. 2008;41(6):381–386
   PubMedGoogle Scholar
• Gotloib L, Sklan D, Mines M. Hemodialysis. Effect on plasma levels of vitamin A and carotenoid. JAMA. 1978;239(8):751
   PubMedGoogle Scholar
• Bonnefont-Rousselot D, Jaudon MC, Issad B, et al. Antioxidant status of elderly chronic renal patients treated by continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 1997;12(7):1399–1405
   PubMed Web of Science ®Google Scholar
• Sundl I, Roob JM, Meinitzer A, et al. Antioxidant status of patients on peritoneal dialysis: associations with inflammation and glycoxidative stress. Perit Dial Int. 2009;29(1):89–101
   PubMedGoogle Scholar
• Yatzidis H, Digenis P, Koutsicos D. Hypervitaminosis A in chronic renal failure after transplantation. Br Med J. 1976;2(6043):1075
   PubMedGoogle Scholar
• Kalousová M, Kubena AA, Kostírová M, et al. Lower retinol levels as an independent predictor of mortality in long-term hemodialysis patients: a prospective observational cohort study. Am J Kidney Dis. 2010;56(3):513–521
   PubMed Web of Science ®Google Scholar
• Espe KM, Raila J, Henze A, et al. German Diabetes and Dialysis Study Investigators. Impact of vitamin A on clinical outcomes in hemodialysis patients. Nephrol Dial Transplant. 2011;26(12):4054–4061
   PubMed Web of Science ®Google Scholar
• Yilmaz MI, Sonmez A, Saglam M, et al. Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial. Am J Kidney Dis. 59(2):177–185
   PubMedGoogle Scholar
• Matias PJ, Jorge C, Ferreira C, et al. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol. 2010;5(5):905–911
   PubMed Web of Science ®Google Scholar
• Zheng Z, Shi H, Jia J, Li D, Lin S. Vitamin D supplementation and mortality risk in chronic kidney disease: a meta-analysis of 20 observational studies. BMC Nephrol. 2013;14:199
   PubMedGoogle Scholar
• Akin F, Ayça B, Köse N, et al. Serum vitamin D levels are independently associated with severity of coronary artery disease. J Investig Med. 2012;60(6):869–873
   PubMed Web of Science ®Google Scholar
• Pilz S, Iodice S, Zittermann A, Grant WB, Gandini S. Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis. 2011;58(3):374–382
   PubMed Web of Science ®Google Scholar
• Icardi A, Paoletti E, De Nicola L, Mazzaferro S, Russo R, Cozzolino M. Renal anaemia and EPO hyporesponsiveness associated with vitamin D deficiency: the potential role of inflammation. Nephrol Dial Transplant. 2013;28(7):1672–1679
   PubMedGoogle Scholar
• Daroux M, Shenouda M, Bacri JL, Lemaitre V, Vanhille P, Bataille P. Vitamin D2 versus vitamin D3 supplementation in hemodialysis patients: a comparative pilot study. J Nephrol. 2013;26(1):152–157
   PubMedGoogle Scholar
• Westenfeld R, Krueger T, Schlieper G, et al. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis. 2012;59(2):186–195
   PubMed Web of Science ®Google Scholar
• Cranenburg EC, Schurgers LJ, Uiterwijk HH, et al. Vitamin K intake and status are low in hemodialysis patients. Kidney Int. 2012;82(5):605–610
   PubMed Web of Science ®Google Scholar
• Pilkey RM, Morton AR, Boffa MB, et al. Subclinical vitamin K deficiency in hemodialysis patients. Am J Kidney Dis. 2007;49(3):432–439
   PubMed Web of Science ®Google Scholar
• Stankowiak-Kulpa H, Krzyżanowska P, Kozioł L, et al. Vitamin K status in peritoneally dialyzed patients with chronic kidney disease. Acta Biochim Pol. 2011;58(4):617–620
   PubMedGoogle Scholar
• McCabe KM, Booth SL, Fu X, et al. Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease. Kidney Int. 2013;83(5):835–844
   PubMedGoogle Scholar
• Małyszko J, Wołczyński S, Skrzydlewska E, Małyszko JS, Myśliwiec M. Vitamin K status in relation to bone metabolism in patients with renal failure. Am J Nephrol. 2002;22(5–6):504–508
   PubMedGoogle Scholar
• Ochiai M, Nakashima A, Takasugi N, et al. Vitamin K2 alters bone metabolism markers in hemodialysis patients with a low serum parathyroid hormone level. Nephron Clin Pract. 2011;117(1):c15–c19
   PubMedGoogle Scholar
• Westenfeld R, Krueger T, Schlieper G, et al. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis. 2012;59(2):186–195
   PubMed Web of Science ®Google Scholar
• Kohlmeier M, Saupe J, Shearer MJ, Schaefer K, Asmus G. Bone health of adult hemodialysis patients is related to vitamin K status. Kidney Int. 1997;51(4):1218–1221
   PubMedGoogle Scholar
• Rodriguez-Garcia M, Gomez-Alonso C, Naves-Diaz M, Diaz-Lopez JB, Diaz-Corte C, Cannata-Andia JB. Vascular calcifications, vertebral fractures and mortality in hemodialysis patients. Nephrol Dial Transplant. 2009;24(1):239–246
   PubMedGoogle Scholar
• Manca-di-Villahermosa S, Giacominelli-Stuffler R, Angelucci CB, Taccone-Gallucci M, Maccarrone M. Vitamin E-related inhibition of monocyte 5-lipoxygenase and cardiovascular outcome in maintenance hemodialysis patients. Recent Pat Inflamm Allergy Drug Discov. 2011;5(3):229–240
   PubMedGoogle Scholar
• Himmelfarb J, Kane J, McMonagle E, et al. Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease. Kidney Int. 2003;64(3):978–991
   PubMed Web of Science ®Google Scholar
• Smith KS, Lee CL, Ridlington JW, Leonard SW, Devaraj S, Traber MG. Vitamin E supplementation increases circulating vitamin E metabolites tenfold in end-stage renal disease patients. Lipids. 2003;38(8):813–819
   PubMed Web of Science ®Google Scholar
• Mafra D, Santos FR, Lobo JC, et al. Alpha-tocopherol supplementation decreases [LDL(-)] in hemodialysis patients. Nephrol Dial Transplant. 2009;24(5):1587–1592
   PubMed Web of Science ®Google Scholar
• Boaz M, Smetana S, Weinstein T, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomized placebo-controlled trial. Lancet. 2000;356:1213–1218
   PubMed Web of Science ®Google Scholar
• Cristol JP, Bosc JY, Badiou S, et al. Erythropoietin and oxidative stress in hemodialysis: beneficial effects of vitamin E supplementation. Nephrol Dial Transplant. 1997;12(11):2312–2317
   PubMedGoogle Scholar
• Antoniadi G, Eleftheriadis T, Liakopoulos V, et al. Effect of one-year oral alpha-tocopherol administration on the antioxidant defense system in hemodialysis patients. Ther Apher Dial. 2008;12(3):237–242
   PubMedGoogle Scholar
• Maccarrone M, Manca-di-Villahermosa S, Meloni C, et al. Arachidonate cascade, apoptosis, and vitamin E in peripheral blood mononuclear cells from hemodialysis patients. Am J Kidney Dis. 2002;40(3):600–610
   PubMedGoogle Scholar
• Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342(3):154–160
   PubMed Web of Science ®Google Scholar
• Mann JF, Lonn EM, Yi Q, et al. HOPE Investigators. Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study. Kidney Int. 2004;65(4):1375–1380
   PubMed Web of Science ®Google Scholar
• El-Hennawy AS, Zaib S. A selected controlled trial of supplementary vitamin E for treatment of muscle cramps in hemodialysis patients. Am J Ther. 2010;17(5):455–459
   PubMedGoogle Scholar
• Floridi A, Piroddi M, Pilolli F, Matsumoto Y, Aritomi M, Galli F. Analysis method and characterization of the antioxidant capacity of vitamin E-interactive polysulfone hemodialyzers. Acta Biomater. 2009;5(8):2974–2982
   PubMedGoogle Scholar
• Piroddi M, Pilolli F, Aritomi M, Galli F. Vitamin E as a functional and biocompatibility modifier of synthetic hemodialyzer membranes: an overview of the literature on vitamin E-modified hemodialyzer membranes. Am J Nephrol. 2012;35(6):559–572
   PubMedGoogle Scholar
• Satoh M, Yamasaki Y, Nagake Y, et al. Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters. Kidney Int. 2001;59(5):1943–1950
   PubMedGoogle Scholar
• Morimoto H, Nakao K, Fukuoka K, et al. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in hemodialysis patients. Nephrol Dial Transplant. 2005;20(12):2775–2782
   PubMedGoogle Scholar
• Yang CC, Hsu SP, Wu MS, Hsu SM, Chien CT. Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress. Kidney Int. 2006;69(4):706–714
   PubMedGoogle Scholar
• Cruz DN, de Cal M, Ronco C. Oxidative stress and anemia in chronic hemodialysis: the promise of bioreactive membranes. Contrib Nephrol. 2008;161:89–98
   PubMed Web of Science ®Google Scholar
• Takouli L, Hadjiyannakos D, Metaxaki P, et al. Vitamin E-coated cellulose acetate dialysis membrane: long-term effect on inflammation and oxidative stress. Ren Fail. 2010;32(3):287–293
   PubMed Web of Science ®Google Scholar
• Baragetti I, Furiani S, Vettoretti S, et al. Role of vitamin E-coated membrane in reducing advance glycation end products in hemodialysis patients: a pilot study. Blood Purif. 2006;24(4):369–376
   PubMedGoogle Scholar
• Libetta C, Zucchi M, Gori E, et al. Vitamin E-loaded dialyzer resets PBMC-operated cytokine network in dialysis patients. Kidney Int. 2004;65(4):1473–1481
   PubMedGoogle Scholar
• Kojima K, Oda K, Homma H, et al. Effect of vitamin E-bonded dialyzer on eosinophilia in hemodialysis patients. Nephrol Dial Transplant. 2005;20(9):1932–1935
   PubMedGoogle Scholar
• Sosa MA, Balk EM, Lau J, et al. A systematic review of the effect of the Excebrane dialyser on biomarkers of lipid peroxidation. Nephrol Dial Transplant. 2006;21:2825–2833
   PubMedGoogle Scholar
• Kobayashi S, Moriya H, Aso K, Ohtake T. Vitamin E-bonded hemodialyzer improves atherosclerosis associated with a rheological improvement of circulating red blood cells. Kidney Int. 2003;63(5):1881–1887
   PubMed Web of Science ®Google Scholar